BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Johnson HM, Lewin AS, Ahmed CM. SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19. Front Immunol 2020;11:582102. [PMID: 33193390 DOI: 10.3389/fimmu.2020.582102] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 La Manna S, Lopez-Sanz L, Bernal S, Fortuna S, Mercurio FA, Leone M, Gomez-Guerrero C, Marasco D. Cyclic mimetics of kinase-inhibitory region of Suppressors of Cytokine Signaling 1: Progress toward novel anti-inflammatory therapeutics. Eur J Med Chem 2021;221:113547. [PMID: 34023736 DOI: 10.1016/j.ejmech.2021.113547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Guo Y, Esfahani F, Shao X, Srinivasan V, Thomo A, Xing L, Zhang X. Integrative COVID-19 biological network inference with probabilistic core decomposition. Brief Bioinform 2021:bbab455. [PMID: 34791019 DOI: 10.1093/bib/bbab455] [Reference Citation Analysis]
3 Akbari M, Akhavan-bahabadi M, Shafigh N, Taheriazam A, Hussen BM, Sayad A, Fathi M, Taheri M, Ghafouri-fard S, Fathi M. Expression analysis of IFNAR1 and TYK2 transcripts in COVID-19 patients. Cytokine 2022. [DOI: 10.1016/j.cyto.2022.155849] [Reference Citation Analysis]
4 Muskiet FAJ, Carrera-bastos P, Pruimboom L, Lucia A, Furman D. Obesity and Leptin Resistance in the Regulation of the Type I Interferon Early Response and the Increased Risk for Severe COVID-19. Nutrients 2022;14:1388. [DOI: 10.3390/nu14071388] [Reference Citation Analysis]
5 Zheng HY, He XY, Li W, Song TZ, Han JB, Yang X, Liu FL, Luo RH, Tian RR, Feng XL, Ma YH, Liu C, Li MH, Zheng YT. Pro-inflammatory microenvironment and systemic accumulation of CXCR3+ cell exacerbate lung pathology of old rhesus macaques infected with SARS-CoV-2. Signal Transduct Target Ther 2021;6:328. [PMID: 34471088 DOI: 10.1038/s41392-021-00734-w] [Reference Citation Analysis]
6 Low ZY, Wen Yip AJ, Chow VTK, Lal SK. The Suppressor of Cytokine Signalling family of proteins and their potential impact on COVID-19 disease progression. Rev Med Virol 2021;:e2300. [PMID: 34546610 DOI: 10.1002/rmv.2300] [Reference Citation Analysis]
7 Zhang Y, Gargan S, Lu Y, Stevenson NJ. An Overview of Current Knowledge of Deadly CoVs and Their Interface with Innate Immunity. Viruses 2021;13:560. [PMID: 33810391 DOI: 10.3390/v13040560] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
8 Wang R, Yang X, Chang M, Xue Z, Wang W, Bai L, Zhao S, Liu E. ORF3a Protein of Severe Acute Respiratory Syndrome Coronavirus 2 Inhibits Interferon-Activated Janus Kinase/Signal Transducer and Activator of Transcription Signaling via Elevating Suppressor of Cytokine Signaling 1. Front Microbiol 2021;12:752597. [PMID: 34650546 DOI: 10.3389/fmicb.2021.752597] [Reference Citation Analysis]
9 Rochette L, Ghibu S. Mechanics Insights of Alpha-Lipoic Acid against Cardiovascular Diseases during COVID-19 Infection. Int J Mol Sci 2021;22:7979. [PMID: 34360751 DOI: 10.3390/ijms22157979] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Rochette L, Zeller M, Cottin Y, Vergely C. GDF15: an emerging modulator of immunity and a strategy in COVID-19 in association with iron metabolism. Trends Endocrinol Metab 2021;32:875-89. [PMID: 34593305 DOI: 10.1016/j.tem.2021.08.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Valori M, Jansson L, Tienari PJ. CD8+ cell somatic mutations in multiple sclerosis patients and controls-Enrichment of mutations in STAT3 and other genes implicated in hematological malignancies. PLoS One 2021;16:e0261002. [PMID: 34874980 DOI: 10.1371/journal.pone.0261002] [Reference Citation Analysis]